Organophosphate insecticides represent one of the most widely used classes
of pesticides with high potential for human exposure in both rural and resi
dential environments. We investigated the interaction of the organophosphot
hioate pesticide fenitrothion (O,O-dimethyl O-(4-nitro-m-tolyl) phosphoroth
ioate) with the human androgen receptor (AR). Fenitrothion blocked dihydrot
estosterone-dependent AR activity in a concentration-dependent and competit
ive manner in HepG2 human hepatoma liver cells transiently transfected with
human AR and an AR-dependent luciferase reporter gene. Schild regression a
nalysis yielded an equilibrium dissociation constant value of 2.18 x 10(-8)
M. To determine the antiandrogenic potential of fenitrothion in vivo, 7-we
ek-old castrated Sprague-Dawley rats were dosed once a day for 7 days with
testosterone propionate (50 mug/day, sc) plus gavage doses of either corn o
il vehicle or fenitrothion (15 or 30 mg/kg/day). An additional group of rat
s was given testosterone propionate and flutamide (50 mg/kg/day). Motor act
ivity and acetylcholinesterase activity in whole blood and brain were also
assessed. Both fenitrothion and the reference antiandrogen flutamide caused
significant decreases in the ventral prostate, seminal vesicle, and levato
r ani plus bulbocavernosus muscles tissue weights. In contrast, blood acety
lcholinesterase activity, a standard biomarker of organophosphate poisoning
, was only inhibited at the higher dose of fenitrothion (30 mg/kg). Our res
ults demonstrate that fenitrothion is a competitive AR antagonist, comparab
le in potency to the pharmaceutical antiandrogen flutamide and more potent,
based on in vitro assays, than the known environmental antiandrogens linur
on and p,p'-, 2,2-bis(p-hydroxyphenyl)-1,1-dichloroethylene (p,p'-DDE).